Figure 5From: Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis The changes of urinary suPAR levels in patients with primary FSGS during follow up. A. Patients with complete remission; B. Patients with non-complete remission. FSGS, focal segmental glomerulosclerosis; suPAR, soluble urokinase receptor.Back to article page